Abstract
THE EFFECT OF BETARGIN ON THE INDICATORS OF CHRONIC SYSTEMIC IN- FLAMMATION, ENDOTHELIAL DYSFUNCTION AND ANTIOXIDANT DEFENSE IN PATIENTS WITH CORONARY HEART DISEASE CONCURRENT WITH NON-ALCO- HOLIC FATTY LIVER DISEASE